Zai Lab Announces Upcoming Presentations in June Investor Conferences

Rhea-AI Summary

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) has announced its participation in several virtual investor conferences in June 2021. The schedule includes a presentation at the Jefferies Healthcare Conference on June 2 at 10:00 a.m. EDT, a panel at the J.P. Morgan Global China Summit on June 3 at 10:45 a.m. HKT, and a fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8 at 8:50 a.m. EDT. Live webcasts will be available on the company’s website, along with archived replays for 90 days post-event.

SHANGHAI and SAN FRANCISCO, May 25, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that management from Zai Lab will be presenting at the following upcoming virtual investor conferences in June:

Jefferies Healthcare Conference 2021
Presentation: Wednesday, June 2, 2021 at 10:00 a.m. EDT

J.P. Morgan Global China Summit
Panel Discussion: Thursday, June 3, 2021 at 10:45 a.m. HKT

Goldman Sachs 42nd Annual Global Healthcare Conference
Fireside Chat: Tuesday, June 8, 2021 at 8:50 a.m. EDT

Live webcasts of the conferences will be available under “Events & Presentations” in the “Investor Relations” section of Zai Lab’s website. An archived replay will be available for 90 days following the event.

About Zai Lab

Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company focused on developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders and infectious disease. To that end, our experienced team has secured partnerships with leading global biopharmaceutical companies in order to generate a broad pipeline of innovative marketed products and product candidates. We have also built an in-house team with strong product discovery and translational research capabilities and are establishing a pipeline of proprietary product candidates with global rights. Our vision is to become a leading global biopharmaceutical company, discovering, developing, manufacturing and commercializing our portfolio in order to impact human health worldwide.

For additional information about the company, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.

For more information, please contact:

ZAI LAB CONTACTS:

Zai Lab
Billy Cho, CFO
+86 137 6151 2501
billy.cho@zailaboratory.com

Media: Ryo Imai / Robert Flamm, Ph.D.
Burns McClellan, on behalf of Zai Lab
212-213-0006 ext. 315 / 364
rimai@burnsmc.com / rflamm@burnsmc.com

Investors: Pete Rahmer / Mike Zanoni
Endurance Advisors, on behalf of Zai Lab
415-515-9763 / 610-442-8570
prahmer@enduranceadvisors.com / mzanoni@enduranceadvisors.com

Zai Lab Limited

Source: Zai Lab Limited

FAQ

What conferences will Zai Lab (ZLAB) attend in June 2021?

Zai Lab will present at the Jefferies Healthcare Conference on June 2, participate in the J.P. Morgan Global China Summit on June 3, and have a fireside chat at the Goldman Sachs Global Healthcare Conference on June 8.

When can I watch Zai Lab's (ZLAB) conference presentations?

Live webcasts of Zai Lab's presentations will be available on their website, with archived replays accessible for 90 days following each event.

What is Zai Lab's focus as a biopharmaceutical company?

Zai Lab is dedicated to developing therapies for unmet medical needs in oncology, autoimmune disorders, and infectious diseases.

Where can I find more information on Zai Lab (ZLAB)?

Additional information about Zai Lab can be found on their official website www.zailaboratory.com.